Vardhaman Laboratories Limited reported standalone unaudited earnings results for third quarter and nine months ended Dec. 31, 2016. For the quarter, the company reported net sales/loss from operations of INR 0.19 million, loss from operations before other income and finance costs and exceptional items of INR 0.10 million, loss from ordinary activities before tax of INR 0.10 million, net loss of INR 0.10 million or INR 0.02 Per basic and diluted share compared to the net sales/loss from operations of INR 0.28 million, loss from operations before other income and finance costs and exceptional items of INR 0.16 million, loss from ordinary activities before tax of INR 0.16 million, net loss of INR 0.16 million or INR 0.04 Per basic and diluted share for the same quarter a year ago. For the year to date, the company reported net sales/income from operations of INR 0.59 million, loss from operations before other income and finance costs and exceptional items of INR 0.31 million, loss from ordinary activities before tax of INR 0.31 million, net loss of INR 0.31 million or INR 0.08 Per basic and diluted share compared to the net sales/income from operations of INR 0.53 million, loss from operations before other income and finance costs and exceptional items of INR 0.17 million, loss from ordinary activities before tax of INR 0.17 million, net loss of INR 0.17 million or INR 0.04 Per basic and diluted share for the same period a year ago.